April 10, 2019

Gastric bypass surgery description, cost and risks associated with weight loss surgeries

January 21, 2015

Massachusetts Life Sciences Center Awards Avaxia Biologics a Universal Partnerships (UP) Program Grant

November 21, 2014

Avaxia Biologics Receives FDA Orphan Drug Designation for AVX-470 for the Treatment of Pediatric Ulcerative Colitis

October 16, 2014

Avaxia Biologics To Present AVX-470 Phase 1b Clinical Results at Upcoming Medical Conferences

May 21, 2014

Avaxia CEO Barbara Fox is Named an EY Entrepreneur Of The Year™ 2014 Award Finalist in New England

May 1, 2014

Avaxia Biologics Reports that Lead Product AVX-470 Achieves Objectives in Phase 1b Clinical Trial in Ulcerative Colitis

February 11, 2014

Avaxia Biologics Awarded Patent with Broad Coverage over Oral Anti-TNF Antibodies for Inflammatory Bowel Disease

October 3, 2013

Avaxia Biologics Appoints Kevin Sarney, CPA, as Vice President, Finance and Administration

July 10, 2013

Avaxia Biologics Appoints Neil L. Schauer, Ph.D., as Vice President, Technical Operations

June 7, 2013

Avaxia Biologics Closes Series B Financing with Total Proceeds of $11.4 Million

March 26, 2013

Avaxia Biologics Appoints Deborah S. Hartman, Ph.D. as Vice President, Research

February 25, 2013

Avaxia Biologics Announces First Patient Dosed in Phase 1b Study of AVX-470 in Ulcerative Colitis

December 18, 2012

Avaxia Biologics Raises $6.4 Million in Series B Financing

November 27, 2012

Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis

September 18, 2012

Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity

June 12, 2012

Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development

May 22, 2012

Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation

April 26, 2012

Avaxia Biologics Elects Christopher Kiritsy to its Board of Directors

March 12, 2012

Avaxia Biologics Awarded $1.5 Million Phase II SBIR Grant from NIH to Develop Oral Antibody Therapeutic for Inflammatory Bowel Disease

March 1, 2012

Avaxia Biologic's Barbara Fox Named One of Mass High Tech's Women to Watch in 2012

February 14, 2012

Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease

December 13, 2011

Avaxia Biologics is Awarded Patent for its Proprietary Orally Active Antibody for Celiac Disease

November 10, 2011

Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease

October 26, 2011

Avaxia Biologics Opens New Office and Labs in Lexington, Massachusetts

August 3, 2011

Avaxia Biologics, Inc. Awarded BARDA Contract for Therapeutic Countermeasure to Help the Nation Respond to a Radiological Emergency

March 10, 2011

Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease